Schonfeld Strategic Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-46,830
| Closed | -$1.53M | – | 2369 |
|
|
2025
Q1 | $1.53M | Buy |
46,830
+36,100
| +336% | +$1.18M | 0.01% | 976 |
|
|
2024
Q4 | $388K | Buy |
+10,730
| New | +$388K | ﹤0.01% | 1444 |
|
|
2024
Q1 | – | Sell |
-32,219
| Closed | -$932K | – | 2183 |
|
|
2023
Q4 | $932K | Sell |
32,219
-4,939
| -13% | -$143K | 0.01% | 990 |
|
|
2023
Q3 | $1.02M | Sell |
37,158
-61,730
| -62% | -$1.7M | 0.01% | 899 |
|
|
2023
Q2 | $2.97M | Sell |
98,888
-24,745
| -20% | -$744K | 0.03% | 634 |
|
|
2023
Q1 | $4.48M | Buy |
123,633
+57,728
| +88% | +$2.09M | 0.04% | 471 |
|
|
2022
Q4 | $2.35M | Buy |
65,905
+49,105
| +292% | +$1.75M | 0.02% | 760 |
|
|
2022
Q3 | $569K | Buy |
+16,800
| New | +$569K | ﹤0.01% | 1634 |
|
|
2022
Q2 | – | Sell |
-79,801
| Closed | -$2.58M | – | 2866 |
|
|
2022
Q1 | $2.58M | Buy |
79,801
+67,501
| +549% | +$2.18M | 0.02% | 600 |
|
|
2021
Q4 | $359K | Buy |
+12,300
| New | +$359K | ﹤0.01% | 1367 |
|
|
2017
Q4 | – | Sell |
-19,967
| Closed | -$799K | – | 850 |
|
|
2017
Q3 | $799K | Buy |
+19,967
| New | +$799K | 0.07% | 302 |
|